Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Pfizer's rival 20-valent candidate was granted priority review in December 2020

- PMLiVE

Pfizer makes first investments through ‘breakthrough growth’ fund

Pharma giant invested $120m in four biotechs in the second half of 2020

- PMLiVE

AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine

CHMP could reach a decision on opinion by 29 January

- PMLiVE

Publicis Health appoints Kara Dugan as president of Razorfish Health

Dugan has spent over a decade at Publicis Health

- PMLiVE

BioNTech boosts COVID-19 vaccine capacity and aims to deliver 2 billion doses in 2021

Company will also publish data on vaccine's efficacy against new variants soon

- PMLiVE

Lilly’s anti-amyloid antibody donanemab renews Alzheimer’s hopes

Drug demonstrated a 'significant' slowing of cognitive decline

Sanofi reception

Sanofi gains access to antibody tech with Kymab acquisition

French pharma will receive global rights to phase 2a monoclonal antibody

- PMLiVE

Sandra Carey takes on global president, expert audiences role at McCann Health

Internal promotion sees Carey take the helm of McCann's expert audience practice

- PMLiVE

bluebird bio to separate oncology and rare diseases units

New oncology company will be led by current bluebird bio CEO Nick Leschly

- PMLiVE

Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma

Study will enrol patients who have ‘unmet clinical needs’ after receiving gene therapy

Roche Basel Switzerland

Roche’s flu pill Xofluza gains EU approval

EU approval is based on results from three phase 3 studies

- PMLiVE

New NHS COVID-19 vaccination centres open as cases surge in the UK

NHS is aiming to vaccinate around 15 million people by mid-February

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links